Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Susan Y WuEthan P DamronJie XuPenny Q FangJulia DaiRanjit NairLuis E Malpica CastilloLuis E FayadCarlos A Torres-CabalaL Jeffrey MedeirosFrancisco VegaRoberto N MirandaMadeleine DuvicChelsea C PinnixBouthaina S DabajaSwaminathan P IyerAuris O HuenJillian R GuntherPublished in: International journal of dermatology (2024)
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder has excellent outcomes, and management strategies may include observation following biopsy, steroids, or radiation. Ultra-low-dose radiotherapy results in excellent outcomes with limited toxicity and is effective for persistent lesions after steroidal therapy.
Keyphrases
- low dose
- epstein barr virus
- early stage
- radiation induced
- locally advanced
- radiation therapy
- high resolution
- high dose
- stem cells
- squamous cell carcinoma
- nk cells
- ultrasound guided
- anti inflammatory drugs
- metabolic syndrome
- combination therapy
- skeletal muscle
- rectal cancer
- fine needle aspiration
- diffuse large b cell lymphoma